Stories Tagged: JN.1

🤷🤷🤷
US FDA Staff Recommends COVID-19 Vaccines Target JN.1 and KP.2 Subvariants in 2024-25 Campaign

Novavax, a pharmaceutical company, is awaiting a decision from the US Food and Drug... (20 revisions)